Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Randomized clinical trial comparing customized corneal crosslinking: Epi-on in high oxygen and epi-off in room air for keratoconus
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Ophthalmology.ORCID iD: 0000-0002-1855-3207
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Ophthalmology.ORCID iD: 0000-0002-8456-8036
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Ophthalmology.
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Ophthalmology.ORCID iD: 0000-0001-6652-7436
2024 (English)In: Journal of cataract and refractive surgery, ISSN 0886-3350, E-ISSN 1873-4502, Vol. 50, no 7, p. 746-753Article in journal (Refereed) Published
Abstract [en]

Purpose: To compare clinical outcomes of customized transepithelial (epi-on) corneal crosslinking (CXL) in high oxygen and customized CXL with epithelial removal (epi-off) in room air for keratoconus (KC).

Setting: Umeå University Hospital, Umeå, Sweden.

Design: Prospective, randomized, single-masked, intraindividually comparing study.

Methods: 32 participants with bilateral progressive KC were treated with bilateral customized topography-guided CXL, 30 mW/cm2; 7.2 to 15 J/cm2and were randomized to epi-on in one eye (32 eyes) and epi-off in the fellow eye (32 eyes). Uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), maximal keratometry (Kmax), subjective ocular discomfort, low-contrast visual acuities (LCVAs) at 10% and 2.5% contrast, ocular and anterior corneal wavefront aberrations, manifest refractive spherical equivalent, endothelial cell count (ECC), and adverse events were assessed through 24 months.

Results: Both treatments showed improvements at 24 months in UDVA; -0.16 ± 0.24 (P <.001) and -0.13 ± 0.20 logMAR (P =.006), respectively, CDVA; -0.10 ± 0.11 (P <.001) and -0.10 ± 0.12 (P =.001), Kmax; -1.74 ± 1.31 (P <.001) and -1.72 ± 1.36 D (P <.001). LCVA 10% improved for both protocols (P <.001), but LCVA 2.5% improved for epi-on CXL only (P =.001). ECC was unaltered, and no adverse events occurred. The epi-on eyes had significantly less discomfort symptoms during the whole first week posttreatment (P <.05).

Conclusions: High-oxygen customized epi-on CXL is a viable alternative to room air customized epi-off CXL, with faster improvements in CDVA and LCVA and less early ocular discomfort.

Place, publisher, year, edition, pages
Wolters Kluwer, 2024. Vol. 50, no 7, p. 746-753
National Category
Ophthalmology
Identifiers
URN: urn:nbn:se:umu:diva-227546DOI: 10.1097/j.jcrs.0000000000001442PubMedID: 38465837Scopus ID: 2-s2.0-85196901462OAI: oai:DiVA.org:umu-227546DiVA, id: diva2:1881665
Available from: 2024-07-03 Created: 2024-07-03 Last updated: 2024-11-11Bibliographically approved
In thesis
1. Advanced crosslinking for keratoconus and low-grade myopia
Open this publication in new window or tab >>Advanced crosslinking for keratoconus and low-grade myopia
2024 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
Avancerad crosslinking för keratokonus och låggradig myopi
Abstract [en]

Corneal crosslinking (CXL) is an established treatment for progressive keratoconus (KC). In this thesis, Advanced CXL refers to a further development of conventional CXL, which aims to improve the treatment outcomes in KC and can also be used as a refractive treatment for low-grade myopia (near-sightedness). Transepithelial (epi-on) CXL with high oxygen has emerged as an approach to reduce the post-treatment inconveniences. The aim of the three prospective, randomized, intra-individually compared, single-masked studies in this thesis was to continue developing advanced CXL for KC and low-grade myopia.

Studies I and II sought to assess the treatment effects and subjective ocular discomforts in epi-on photorefractive intrastromal crosslinking (PiXL) in high oxygen as a refractive treatment for low-grade myopia using three different illumination protocols. In Study I, 23 healthy subjects (46 eyes) were randomized to a central 4.0 mm homogeneous illumination zone (area) in one eye and a 4.0 mm annular zone with a central 2.0 mm sparing (ring) in the fellow eye. Both protocols improved uncorrected distance visual acuity (UDVA) and manifest refractive spherical equivalent (MRSE) at 1 month, which remained stable throughout 24 months. The ring protocol was reported to cause less ocular discomfort at 1 week. In Study II, 27 healthy subjects (54 eyes) were randomized to the previous ring protocol in one eye and a 3.5 mm annular protocol with a central 1.5 mm sparing (small ring) in the fellow eye. The small ring rendered less ocular discomfort the first day post-treatment and slightly better improvements in UDVA and MRSE, but there was a transient reduction in low-contrast visual acuity (LCVA). In both Studies I and II, no changes in endothelial cell count (ECC) and best corrected visual acuity (BCVA) were seen and no adverse events were registered.

Study III aimed to compare the treatment effect and subjective ocular discomfort scores of customized topography-guided epi-on CXL in high oxygen with customized topography-guided epi-off CXL in room air for KC. At 24 months, both treatments had halted the disease progressions and had improved UDVA and BCVA. LCVA at 10% contrast improved for both protocols, but LCVA at 2.5% contrast improved for epi-on CXL only. No changes were seen in ECC, and no adverse events were registered. The epi-on eyes were reported to have less ocular discomfort throughout the first week post-treatment.

In conclusion, advanced CXL can be used to improve vision and halt progressive KC, and it also improves uncorrected vision and reduces low-grade myopia in healthy eyes. In low-grade myopia, the initial ocular discomfort may be reduced with a ring illumination PiXL protocol. A larger treatment effect may be seen with a smaller treatment zone, but likely at the expense of a transient decrease in LCVA. In KC, customized topography-guided epi-on CXL in high oxygen is a viable alternative to customized topography-guided epi-off CXL in room air, with faster improvements in BCVA and LCVA and less early ocular discomfort.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2024. p. 85
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2328
Keywords
Keratoconus, Myopia, Corneal Cross-linking, Transepithelial CXL, Oxygen, Topography-guided CXL, Visual acuity, Corneal topography
National Category
Ophthalmology
Research subject
ophthalmology
Identifiers
urn:nbn:se:umu:diva-231668 (URN)9789180705134 (ISBN)9789180705141 (ISBN)
Public defence
2024-12-06, Hörsal B, målpunkt 1D T9, Norrlands universitetssjukhus, Umeå, 13:00 (Swedish)
Opponent
Supervisors
Available from: 2024-11-15 Created: 2024-11-11 Last updated: 2024-11-12Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Elving, SofieFredriksson, AnneliBeckman Rehnman, JeannetteBehndig, Anders

Search in DiVA

By author/editor
Elving, SofieFredriksson, AnneliBeckman Rehnman, JeannetteBehndig, Anders
By organisation
Ophthalmology
In the same journal
Journal of cataract and refractive surgery
Ophthalmology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 80 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf